Refine by
Oral Administration Suppliers Serving Iran
17 companies found
based inPescantina (VR), ITALY
We initiate and implement projects for human health. Our products are the result of many years of research and development, experience in the field of plant biochemistry and other natural components. We examine medicinal and endemic plants from all ...
AltaDe 3 – Vitamin D3 (Ñholecalciferol) drops is a product used for prevention and treatment of Vitamin D deficiency in children from born, in adults and ...
based inStafford, VIRGINIA (USA)
We are Hyper-accelerate drug and medical device development. Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to ...
A tool that performs in silico clinical trials to assess the neutropenic effects of a chemotherapeutic agent in a virtual population of cancer patients ...
based inXiangshan County, CHINA
NEWGEN BIOTECH (NINGBO) CO.,LTD is located in No. 5, Rongtai Road, Chengdong Industrial Park, Xiangshan County. It was established in December 2013. The high-tech bioengineering company of bio-enzyme preparation derivatives has developed into a ...
Serrapeptase, which is a high-yield strain of Serratia, is extracted by deep submerged fermentation. This product is widely used in the medical field and is used as an alternative medicine in many countries (such as Japan) and has a long Application ...
based inAhmedabad, INDIA
Established in the year 2013 at Ahmedabad (Gujarat, India), we Heet Healthcare Pvt. Ltd. are noteworthy OEM Manufacturer, Exporter, Trader, Importer and Wholesaler of Pharmaceutical products. The offered products are processed using high-grade ...
Ivermectin 12mg USP Tablets. Composition: Each uncoated dispersible tablets contains : Ivermectin U.S.P. …….12mg, Excipients ………qs, Colour : Erythrosine. USE : This medication is used to treat certain parasitic ...
based inPrinceton, NEW JERSEY (USA)
Origin is a privately-held, clinical-stage biotechnology company founded in June 2010 to develop and commercialize a novel, patented medical technology - delivering therapeutic molecules generated right at the point of care. Our technology is based ...
Nitric Oxide (NO) was first prepared in 1620 and first studied in 1720. It was poorly understood until the late 1900s. The discovery of the role of NO as fundamental to biologic function was so remarkable that hundreds of research papers led Nitric ...
based inMalmö, SWEDEN
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Oncoral is a novel oral irinotecan tablet in ...
Mangoral is a novel oral imaging agent in development for use in MR-imaging of the liver. Mangoral aims to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with severe kidney ...
based inMapo, SOUTH KOREA
MD Healthcare contributes to being healthy through innovative healthcare solutions based on cutting edge science and technology. One of the most revolutionary advances in the biological sciences in recent years has been the realization that ...
That commensal bacteria play an essential role in human health is beyond doubt, and it is now widely accepted that humans are holobionts whose collective metabolic potential exceeds the sum of the individual eukaryotic and prokaryotic components. ...
based inXiamen City,, CHINA
Found in 1999, Huiying Animal Health Co. Ltd. is located in the beautiful garden city—Xiamen, with subsidiary corporations including Xiamen Huiying Animal Science Tech. Co. Ltd., Xiamen Huiying Animal Pharmaceutical Co. Ltd., Xiamen Jundingxin ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
![Ibio - Model 100 - Idiopathic Pulmonary Fibrosis [IPF] Therapeutics](https://d32zuqhgcrpxli.cloudfront.net/eyJidWNrZXQiOiJlZS1maWxlcyIsImtleSI6ImZpbGVzLzEyNTA4Ny9wcm9kdWN0cy84NTMxMzQvMTI1MDg3XzJfMjAyMzAyMTMwNjEwNTM5ODQxNzI5X3Jhdy5wbmciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY29udGFpbiIsImJhY2tncm91bmQiOnsiciI6MjU1LCJnIjoyNTUsImIiOjI1NSwiYWxwaGEiOjF9LCJ3aWR0aCI6MTQzLCJoZWlnaHQiOjEwMn19fQ== "Ibio - Model 100 - Idiopathic Pulmonary Fibrosis [IPF] Therapeutics")
Idiopathic pulmonary fibrosis [IPF] is a form of progressive pulmonary fibrosis, or abnormal scarring of the lungs. As the disease progresses, the increased scarring leads to decreasing transfer of oxygen into the bloodstream, and ultimately, ...
based inBasel, SWITZERLAND
We at Auris Medical are a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders. We are focusing on the development of intranasal betahistine ...
AM-125 for the treatment of vertigo is expected to complete its Phase 2 TRAVERS trial in Q2 2022 and to move into Phase 3 in Q4 2022. Keyzilen® (AM-101) for the treatment of acute inner ear tinnitus and Sonsuvi® (AM-111) for the treatment of ...
based inTucson, ARIZONA (USA)
Novel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better ...
Only 4 of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009, but this medicine did not extend life expectancy. Patients deserve better therapies that extend life and ...
based inZhengzhou City, CHINA
ZackenBio, a leading manufacturer of functional probiotics strains, specializes in promoting probiotic solutions in animal health and nutrition, sustainable agriculture and eco-friendly environmental industries. A pioneer of probiotic strains and ...
based in, NEW YORK (USA)
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging ...
ACCURETXC is a fixed-combination tablet that combines an angiotensin-converting enzyme (ACE) inhibitor, quinapril hydrochloride, and a thiazide diuretic, ...
based inRoden, NETHERLANDS
Pure Inhalation Medication Systems (PureIMS) is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops. The focus is on the treatment of ...
Amikacin Cyclops™ is an amikacin dry powder inhaler for the treatment of tuberculosis (TB). Inhaled amikacin from the Cyclops™ will result in higher amikacin concentrations in the lungs than conventional infusion or intramuscular ...
based inNanjing, CHINA
Founded in 2013, Frontier Biotechnologies Inc. (“Frontier Biotech”) is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, ...
Aikening ® is a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. Aikening ® represents multiple technological breakthroughs in the aspects of the polypeptide sequence, chemical modification, molecular target, as ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceutical Solutions specializes in comprehensive drug development services, providing tailored formulation and manufacturing solutions from pre-formulation stages to commercialization. With a focus on overcoming pharmaceutical ...
based inNew York City, NEW YORK (USA)
Lauren Sciences is a privately-held New York biotechnology company focused on developing its V-Smart platform to create a robust pipeline of V-Smart therapeutics consisting of central nervous system (CNS)-active drugs that normally do not cross the ...
V-Smart Platform, breakthrough innovation, winning trifecta for brain delivery, enables non-invasive, triple-targeted CNS delivery of non-BBB penetrant therapeutic agents (nucleic acids, antibodies, biologics, small molecules, ...